Eli Lilly stock soars after Q1 earnings as revenue grows 56% on strength of GLP-1 drug sales
Original Source
Read the full article at Finance →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.